Two of the nation’s largest tobacco companies, Altria and Reynolds American, are moving forward with plans to launch new smokeless alternative products without waiting for formal marketing orders from the U.S. Food and Drug Administration (FDA). The companies argue that the FDA has failed to adhere to statutory deadlines for reviewing new product applications, creating a market imbalance where illegal, unauthorized vapes proliferate while their own regulated products are stuck in a lengthy review process.